Takara Bio (TSE:4974) Total Liabilities : 円9,470 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Takara Bio Total Liabilities?

Takara Bio's Total Liabilities for the quarter that ended in Mar. 2024 was 円9,470 Mil.

Takara Bio's quarterly Total Liabilities declined from Sep. 2023 (円11,155.00 Mil) to Dec. 2023 (円10,560.00 Mil) and declined from Dec. 2023 (円10,560.00 Mil) to Mar. 2024 (円9,470.00 Mil).

Takara Bio's annual Total Liabilities declined from Mar. 2022 (円19,650.00 Mil) to Mar. 2023 (円16,750.00 Mil) and declined from Mar. 2023 (円16,750.00 Mil) to Mar. 2024 (円9,470.00 Mil).

Takara Bio Total Liabilities Historical Data

The historical data trend for Takara Bio's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takara Bio Total Liabilities Chart

Takara Bio Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

8,420.00

15,450.00

19,650.00

16,750.00

9,470.00

Takara Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															16,750.00	12,457.00	11,155.00	10,560.00	9,470.00

Takara Bio Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Takara Bio's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7168	+	(788	+	412
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	1102)
	=	9,470

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	121252	-	111782
	=	9,470

Takara Bio's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7168	+	(788	+	412
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	1102)
	=	9,470

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	121252	-	111782
	=	9,470

Takara Bio Total Liabilities Related Terms

Thank you for viewing the detailed overview of Takara Bio's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Takara Bio (TSE:4974) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Takara Bio Inc (TSE:4974) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

TF2:Germany

Address

Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058

Website

http://www.takara-bio.co.jp

Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.

Takara Bio (TSE:4974) Headlines

No Headlines